)
Solid Biosciences (SLDB) investor relations material
Solid Biosciences AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting called to order as a virtual-only event, ensuring stockholders have full participation rights and opportunities to ask questions.
Introductions made for board members, executive team, legal counsel, and Inspector of Election.
Corporate governance
Notice of annual meeting and proxy statement were sent to all stockholders of record as of April 16, 2026.
Quorum established with 86.57% of shares represented, allowing business to proceed.
Board and executive committee updates
Election of three Class II directors (Clare Kahn, Adam Stone, Lynne Sullivan) to serve until the 2029 annual meeting.
Ratification of Ilan Ganot as a Class I director on an advisory basis until the 2028 annual meeting.
- Gene therapy programs show robust efficacy, safety, and regulatory momentum for key indications.SLDB
Goldman Sachs 47th Annual Global Healthcare Conference 20268 Jun 2026 - Duchenne and FA gene therapy programs show strong progress, with pivotal FDA meetings ahead.SLDB
Jefferies Global Healthcare Conference 20263 Jun 2026 - Key clinical progress, $380.7M cash, and a $56.7M net loss with runway into 2028.SLDB
Q1 202613 May 2026 - Key votes include director elections, auditor ratification, and doubling authorized shares.SLDB
Proxy filing23 Apr 2026 - Stockholders will vote on director elections, auditor ratification, share increase, and executive pay.SLDB
Proxy filing23 Apr 2026 - Gene therapy programs show strong safety, efficacy, and innovation, with key data readouts ahead.SLDB
25th Annual Needham Virtual Healthcare Conference14 Apr 2026 - Virtual meeting to vote on directors, auditor, share increase, and executive pay; board supports all.SLDB
Proxy filing10 Apr 2026 - Strong clinical progress and $240M financing extend cash runway into 2028 despite higher net loss.SLDB
Q4 202520 Mar 2026 - 42.8 million shares registered for resale after a $240M private placement in gene therapy.SLDB
Registration filing19 Mar 2026
Next Solid Biosciences earnings date
Next Solid Biosciences earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)